DK1302207T3 - Fremgangsmåde til at fremstille et antihypertensivt middel indeholdende et dipeptid som virkningsfuld bestanddel - Google Patents

Fremgangsmåde til at fremstille et antihypertensivt middel indeholdende et dipeptid som virkningsfuld bestanddel

Info

Publication number
DK1302207T3
DK1302207T3 DK02080463T DK02080463T DK1302207T3 DK 1302207 T3 DK1302207 T3 DK 1302207T3 DK 02080463 T DK02080463 T DK 02080463T DK 02080463 T DK02080463 T DK 02080463T DK 1302207 T3 DK1302207 T3 DK 1302207T3
Authority
DK
Denmark
Prior art keywords
agent containing
dipeptide
preparing
antihypertensive agent
effective ingredient
Prior art date
Application number
DK02080463T
Other languages
Danish (da)
English (en)
Inventor
Naoyuki Yamamoto
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Application granted granted Critical
Publication of DK1302207T3 publication Critical patent/DK1302207T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/80—Antihypertensive peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK02080463T 1996-08-02 1997-08-01 Fremgangsmåde til at fremstille et antihypertensivt middel indeholdende et dipeptid som virkningsfuld bestanddel DK1302207T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20466596 1996-08-02

Publications (1)

Publication Number Publication Date
DK1302207T3 true DK1302207T3 (da) 2007-11-05

Family

ID=16494265

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02080463T DK1302207T3 (da) 1996-08-02 1997-08-01 Fremgangsmåde til at fremstille et antihypertensivt middel indeholdende et dipeptid som virkningsfuld bestanddel
DK97305820T DK0821968T3 (da) 1996-08-02 1997-08-01 Anti-hypertensivt middel

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK97305820T DK0821968T3 (da) 1996-08-02 1997-08-01 Anti-hypertensivt middel

Country Status (8)

Country Link
US (1) US5854029A (fr)
EP (2) EP0821968B1 (fr)
JP (2) JP3364579B2 (fr)
AT (2) ATE238825T1 (fr)
DE (2) DE69721407T2 (fr)
DK (2) DK1302207T3 (fr)
ES (2) ES2196263T3 (fr)
PT (1) PT1302207E (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998259B1 (en) 1999-05-20 2006-02-14 Davisco Foods International Enzymatic treatment of whey proteins for the production of antihypertensive peptides and the resulting products
WO2001085984A1 (fr) * 2000-05-08 2001-11-15 Davisco Foods International, Inc. Traitement enzymatique des proteines de lactoserum permettant d'obtenir des peptides anti-hypertension, produits obtenus et traitement de l'hypertension chez les mammiferes
US6630320B1 (en) 2000-05-08 2003-10-07 Devisco Foods International, Inc. Treatment of hypertension in mammals with hydrolyzed whey proteins
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
TWI225070B (en) 1999-12-01 2004-12-11 Food Industry Res & Dev Inst Novel peptides used as angiotensin converting enzyme inhibitor and preparation process thereof
AU2001247334A1 (en) * 2000-03-10 2001-09-24 Monsanto Company Novel peptides with anti-hypertensive activity
WO2001068113A1 (fr) * 2000-03-10 2001-09-20 Monsanto Technology Llc Peptides antihypertenseurs
WO2004015125A1 (fr) 2002-08-09 2004-02-19 Chr. Hansen A/S Procede concernant l'elaboration de peptides a proprietes anti-hypertension
EP1466529A1 (fr) * 2003-04-07 2004-10-13 Chr. Hansen A/S Composition destinée à reduire la fréquence cardiaque
US7718171B2 (en) 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
JP4680571B2 (ja) * 2003-12-25 2011-05-11 カルピス株式会社 経口摂取用保湿剤
EP1796480B1 (fr) 2004-09-03 2011-11-09 Chr. Hansen A/S Lait fermente comprenant un ligand de recepteur et utilisations correspondantes
JP4635159B2 (ja) * 2005-09-05 2011-02-16 独立行政法人農業・食品産業技術総合研究機構 Ｇａｂａを高濃度に含有する食用植物体及びその製造方法
JP4868619B2 (ja) * 2005-09-05 2012-02-01 独立行政法人農業・食品産業技術総合研究機構 ビタミンＵ、タウリン、カルノシン、Ｔｙｒ−Ｐｒｏおよび／またはＬ−カルニチンを高濃度に含有する食用植物体及びその製造方法
EP2161029A1 (fr) * 2008-09-09 2010-03-10 Unilever N.V. Composition comprenant des peptides
DE602008004345D1 (de) * 2008-09-09 2011-02-17 Unilever Nv Nahrungsmittel enthaltend Dipeptide mit blutdrucksenkenden Eigenschaften.
TW201039839A (en) * 2009-03-27 2010-11-16 Calpis Co Ltd Composition for regulating antonomic nervous activity and method for regulating autonomic nervous
AU2011327288B2 (en) * 2010-11-09 2015-05-07 Asahi Group Holdings, Ltd. Lactobacillus helveticus having high proteolysis activity
US8673862B1 (en) 2012-09-06 2014-03-18 Food Industry Research And Development Institute Peptides and use thereof in the inhibition of angiotensin converting enzyme
WO2017222029A1 (fr) * 2016-06-23 2017-12-28 国立大学法人鳥取大学 Lait fermenté présentant une activité inhibitrice d'enzyme de conversion de l'angiotensine élevée, et procédé de fabrication de peptide bioactif
JP7453665B2 (ja) 2019-01-29 2024-03-21 国立大学法人鳥取大学 ジペプチジルペプチダーゼｉｖ阻害活性が高い発酵乳およびその製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3047596A1 (de) * 1980-12-17 1982-07-22 Victor Dipl.- Chem. 8000 München Brantl Pharmakologisch aktive dipeptide
JP3782837B2 (ja) * 1995-04-10 2006-06-07 カルピス株式会社 血圧降下剤及びその製造法

Also Published As

Publication number Publication date
PT1302207E (pt) 2007-11-08
DE69738185T2 (de) 2008-07-10
DK0821968T3 (da) 2003-06-02
DE69721407D1 (de) 2003-06-05
EP0821968B1 (fr) 2003-05-02
EP0821968A2 (fr) 1998-02-04
EP0821968A3 (fr) 1999-07-14
ES2196263T3 (es) 2003-12-16
EP1302207A2 (fr) 2003-04-16
EP1302207B1 (fr) 2007-10-03
JPH1095736A (ja) 1998-04-14
DE69738185D1 (de) 2007-11-15
US5854029A (en) 1998-12-29
ES2291417T3 (es) 2008-03-01
ATE238825T1 (de) 2003-05-15
JP4713053B2 (ja) 2011-06-29
JP2003048849A (ja) 2003-02-21
EP1302207A3 (fr) 2003-04-23
ATE374617T1 (de) 2007-10-15
DE69721407T2 (de) 2004-05-06
JP3364579B2 (ja) 2003-01-08

Similar Documents

Publication Publication Date Title
DK1302207T3 (da) Fremgangsmåde til at fremstille et antihypertensivt middel indeholdende et dipeptid som virkningsfuld bestanddel
PL323152A1 (en) Derivatives of 1,3-propanodiole as biologically active compounds
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
NZ332780A (en) Substituted amines for the treatment of neurological and neuropsychiatric disorders
HUT74604A (en) Process for the preparation of concentrated, biologically active silicon compounds
HUT49842A (en) Herbicides comprising substituted aryl or heteroaryl-bicyclodione derivatives as active ingredient and process for producing the compounds
WO1993000094A3 (fr) Utilisation de derives de tetrahydrobenzazepine pour le traitement de l'hypertension porte et de la migraine
MY104979A (en) [ 5(6)(ih-azole-1-ylmethyl) benzimidazole] carbamates.
CS440889A2 (en) Method of bu-3608 antibiotics' complex n-alkyl derivatives production
CA2135709A1 (fr) Derives de melatonine servant au traitement des troubles du sommeil
MX9804828A (es) Benzotiazolona etanaminas biologicamente activas.
UA66932C2 (en) Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine
EP0855398A4 (fr) Derives de sesquiterpene a activite antivirale
HUT49873A (en) Herbicides and acaricides, as well as process for producing the active ingredient aryl- or heteroaryldione derivatives
PL338147A1 (en) Derivatives of polyhydroxylbutylpyrazine, method of obtaining and drugs containing them
BG103986A (en) Derivatives of pyrrolidinecarboxylic acids as endotheline antagonists
UA29461C2 (uk) Засіб для лікування амілоїдозу, спосіб лікування амілоїдозу
YU28999A (sh) Postupak za kristalisanje derivata tetrahidropiridina i dobijeni kristalni oblici
IL116262A0 (en) Processes for preparing ranitidine
DE69000806T2 (de) Indol-derivate.
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
FI945414A (fi) Menetelmä N,N-disubstituoidun aminofenolin valmistamiseksi
MX9606264A (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol como sustancias farmacologicas activas.
ZA974928B (en) Process for the preparation of organic salts of N'N-Diacetylcystine.
NO882279D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive endo-bicyklo (2,2,1) heptyl-adenosin-derivater.